Pituitary adenylate cyclase-activating polypeptide causes increased tyrosine phosphorylation of focal adhesion kinase and paxillin

Journal of Molecular Neuroscience

Volumn 46, Issue 1, 2012, Pages 68-74

  Moody, Terry W ^a   Leyton, Julius ^b   Jensen, Robert T ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

FAK; Lung cancer; PACAP; Paxillin; Signal transduction; Tyrosine phosphorylation

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOCHALASIN D; FOCAL ADHESION KINASE; GENISTEIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; PAXILLIN; PHOSPHATIDYLINOSITOL; PHOSPHOLIPASE C; PROTEIN TYROSINE KINASE; TYROSINE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ACTIN POLYMERIZATION; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LUNG CANCER; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION;

CELL LINE, TUMOR; FOCAL ADHESION KINASE 1; HUMANS; PAXILLIN; PHOSPHORYLATION; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; SIGNAL TRANSDUCTION; TYROSINE; UP-REGULATION;

EID: 84858866010     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-011-9639-7     Document Type: Article

References (51)

1. Akiyama T, Isidia J, Nakagawa H, Ogawara S, Vatanabe N, Itoh M, Shibuya M (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinase. Biol Chem 262:5592-5595
2. Arimura A (1992) Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Regul Pept 37:287-303
3. Bellis SL, Perotta JA, Curtis MS, Turner CE (1997) Adhesion of fibroblasts to fibronectin stimulates both serine and tyrosine phosphorylation of paxillin. Biochem J 325:375-381 (Pubitemid 27338716)
4. Bergan R, Kyle E, Nguyen P, Trepel J, Neckers L (1996) Genistein-stimulated adherence of prostate cancer cells is associated with the binding of focal adhesion kinase to beta-1-integrin. Clin Exp Metastasis 14:389-398 (Pubitemid 26363213)
5. Burridge K, Turner CE, Romer LH (1992) Tyrosine phosphorylation of paxillin and p125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J Cell Biol 119:893-903
6. Buscail L, Cambillau C, Seva C, Scemama JL, DeNeef P, Robberecht P, Christophe J, Susini C, Vaysse N (1992) Stimulation of rat pancreatic tumoral AR4-2J cell proliferation by pituitary adenylate cyclase-activating polypeptide. Gastroenterology 103(3):1002-1008
7. Cary LS, Han DC, Poite TR, Hanks SK, Fuan JL (1998) Identification of p130Cas as a mediator of focal adhesion kinase-prompted cell migration. J Cell Biol 140:211-221 (Pubitemid 28070908)
8. Chrzanowski-Wodnick M, Burridge K (1996) Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol 133:1403-1415
9. Cooper JA (1987) Effects of cytochalasin and phalloidin on actin. J Cell Biol 105:1473-1478
10. Draoui M, Hida T, Birrer M, Zia F, Moody TW (1996) PACAP stimulates c-fos mRNAs in small cell lung cancer cells. Life Sci 59(4):307-313 (Pubitemid 26232868)
11. El Zein N, Corazza F, Sariban E (2006) The neuropeptide pituitary adenylate cyclase activating protein is a physiological activator of human monocytes. Cell Signal 18:162-173 (Pubitemid 41527160)
12. Germano PM, Lieu SN, Xue J, Cooke HJ, Christoff GL, Ly Y, Pisegna JR (2009) PACAP induces signaling and stimulation of 5-hydroxytryptamine release and growth in neuroendocrine tumor cells. J Mol Neurosci 39(3):391-401
13. Hanks SK, Calab MD, Harper MC, Patel SK (1992) Focal adhesion protein-tyrosine phosphorylation in response to cell attachment to fibronectin. Proc Natl Acad Sci USA 89:8487-8491
14. Hildebrand JD, Taylor JM, Parsons JT (1996) An SH3 domain containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase. Mol Cell Biol 16:3169-3178 (Pubitemid 26163383)
15. Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S (1992) Functional expression and tissue distribuiton of a novel receptor for vasoactive intestinal polypeptide. Neuron 8:811-819
16. Jones RJ, Brunton VG, Frame MC (2000) Adhesion-linked kinases in cancer: emphasis on Src, focal adhesion kinase and PI 3-kinase. Eur J Cancer 36:1595-1606 (Pubitemid 30616364)
17. Korman LY, Carney DN, Citron ML, Moody TW (1986) Secretin/VIP stimulated secretion of bombesin-like peptides from human small cell lung cancer. Cancer Res 46:1214-1218
18. Lee M, Jensen RT, Bepler G, Korman LY, Moody TW (1990) Vasoactive intestinal polypeptide binds with high affinity to non-small cell lung cancer cells and elevates cAMP levels. Peptides 11:1205-1210
19. Lee FS, Rajagopal R, Kim AH, Chang PC, Shao MV (2002) Activation of Trk neurotropin receptor signaling by pituitary adenylate cyclase-activating polypeptide. J Biol Chem 277:9096-9102 (Pubitemid 34952985)
20. Leyton J, Coelho T, Coy DH, Jakowlew S, Birrer MJ, Wank S, Moody TW (1999) PACAP(6-38) inhibits the growth of prostate cancer cell lines. Cancer Lett 125:131-139
21. Leyton J, Garcia L, Jensen RT, Moody TW (2001) Bombesin and gastrin releasing peptide increase tyrosine phosphorylation of focal adhesion kinase and paxillin in non-small cell lung cancer cells. Cancer Lett 162:87-95
22. Leyton J, Garcia-Marin L, Jensen RT, Moody TW (2002) Neurotensin causes tyrosine phosphorylation of focal adhesion kinase in non-small cell lung cancer cells. Eur J Pharmacol 442:179-186 (Pubitemid 34626192)
23. Lutz EM, Sheward WJ, West KM, Morrow JA, Harmar AJ (1993) The VIP2 receptor molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett 334:3-8
24. Macdonald DS, Weerapura M, Beazely MA, Martin L, Czerwinski W, Roder JC, Orser BA, MacDonald JF (2005) Modulation of NMDA receptor by pituitary adenylate cyclase activating peptide in CA1 neurons requires Gαq, protein kinase C and activation of Src. J Neuroscience 25:11374-11384 (Pubitemid 43083711)
25. May V, Lutz E, MacKenzie C, Schutz K, Dozark K, Braas KM (2010) Pituitary adenylate cyclase-activating polypeptide (PACAP)/PAC1HOP1 receptor activation coordinates multiple neurotrophic signaling pathways. J Biol Chem 285:9749-9761
26. Moody TW, Jensen RT (2006) VIP and PACAP as autocrine growth factors in breast and lung cancer. "Handbook of Biologically active peptides," Kastin, A. (ed), Elsevier Press, 493-498
27. Moody TW, Pert CB, Gazdar AF, Carney DN, Minna JD (1981) High levels of intracellular bombesin characterize human small-cell lung carcinoma. Science 214:1246-1248 (Pubitemid 12167331)
28. Moody TW, Zia F, Draoui M, Brenneman DE, Fridkin M, Davidson A, Gozes I (1993a) A novel VIP antagonist inhibits non-small cell lung cancer growth. Proc Natl Acad Sci USA 90:4345-4349 (Pubitemid 23148900)
29. Moody TW, Zia F, Makheja A (1993b) Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells. Peptides 14(2):241-246
30. Moody TW, Zia F, Bitar K, Coy DH (1994) In: Rosselin G (ed) PACAP(6-38) is a PACAP type I receptor antagonist on small cell lung cancer cells, VIP, PACAP and related regulatory peptides: from molecular biology to clinical applications. World Scientific Publishing Co, Singapore, pp 527-534
31. Moody TW, Czerwinski G, Tarasova NI, Michejda CJ (2002a) VIP-ellipticine derivatives inhibit the growth of breast cancer cells. Life Sci 19:1005-1014 (Pubitemid 34667106)
32. Moody TW, Leyton J, Casibang M, Pisegna J, Jensen RT (2002b) PACAP-27 tyrosine phosphorylates mitogen activated protein kinase and increases VEGF mRNAs in human lung cancer cells. Regul Pept 109:135-140 (Pubitemid 35292404)
33. Moody TW, Chan D, Fahrenkrug J, Jensen RT (2003a) Neuropeptides as autocrine growth factors in cancer cells. Curr Pharm Des 9:495-509 (Pubitemid 36131740)
34. Moody TW, Hill JM, Jensen RT (2003b) VIP as a trophic factor in the CNS and cancer cells. Peptides 24:163-177 (Pubitemid 36165188)
35. Obara Y, Horgan AM, Stork PJS (2007) The requirement of Ras and Rap1 for the activation of ERKs by cAMP, PACAP and KCl in cerebellar granule cells. J Neurochem 101:470-482 (Pubitemid 46525282)
36. Ocak S, Yamashita H, Udyavar AR, Miller AN, Gonzalez AL, Zou Y, Jiang A, Yi Y, Shyr Y, Estrada L, Quaranta V, Massion PP (2010) DNA copy number aberrations in small-cell lung cancer reveal activation of the focal adhesion pathway. Oncogene 29:6331-6342
37. Pisegna J, Wank SA (1993) Molecular cloning and functional expression of the pituitary adenylate cyclase activating polypeptide type I receptor. Proc Natl Acad Sci USA 90:6345-6349 (Pubitemid 23191512)
38. Pisegna JR, Wank SA (1996) Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclase and phospholipase C. J Biol Chem 271:17267-17274 (Pubitemid 26244284)
39. Reubi JC, Laderach U, Waser B, Gebbers JD, Robberecht P, Laissue JA (2000) Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide receptor subtypes in human tumors and their tisssues of origin. Cancer Res 60:3105-3112 (Pubitemid 30395841)
40. Roberts WG, Ung El Whalen P, Cooper B, Hulford C, Autry C (2008) Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor. Cancer Res 68:1935-1944 (Pubitemid 351416580)
41. Rozengurt E (1991) Neuropeptides as cellular growth-factors: role of multiple signaling pathways. Eur J Clin Invest 21:123-134
42. Schaller MD, Borgman CA, Cobb BS, Vaines RR, Reynolds AB, Parsons JT (1992) P125FAK, a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA 89:192-196
43. Schaller MD, Otey CA, Hildebrand JD, Parsons JT (1995) Focal adhesion kinase and paxillin bind to peptides mimicking beta integrin cytoplasmic domains. J Cell Biol 130:1181-1187
44. Sheddon K, Taylor JM, Enkemann SA (2008) Gene expression-based survival prediction in lung adenocarcinoma: a multi-site blinded validation study. Nat Med 14:822-827
45. Sherwood NM, Krueckl SL, McRory JE (2000) The origin and function of the pituitary adenylate cyclase-activating polypeptide have different tissue distributions. Endocrinology 128:3055-3065
46. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, Journot L (1993) Differential signal transduction by five splice variants of the PACAP receptor. Nature 365:170-175 (Pubitemid 23282064)
47. Taniguchi T, Takaishi K, Murayama T, Ito M, Iwata N, Chihara K, Sasaki T, Takai Y, Matsui T (1996) Cholecystokinin-B/gastrin receptors mediate rapid formation of actin stress fibers. Oncogene 12:1357-1360 (Pubitemid 26127266)
48. Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O, Fournier A, Chow BKC, Hashimoto H, Galas L, Vaudry H (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61:283-357
49. Wu DW, Cheng YW, Wang J, Chen CY, Lee H (2010) Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting. Cancer Res 70:10392-10401
50. Xu L, Owens LV, Sturge GC, Yang X, Liu ET, Craven RJ, Chance WG (1996) Attenuation of focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ 7:413-418 (Pubitemid 26362085)
51. Zia F, Fagarasan M, Bitar K, Coy DH, Pisegna J, Wank S, Moody TW (1995) PACAP receptors regulate the growth of non-small cell lung cancer cells. Cancer Res 55:4886-4891